These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 36814443)

  • 1. Gut microbiome and mycobiome in inflammatory bowel disease patients with
    Yu S; Ge X; Xu H; Tan B; Tian B; Shi Y; Dai Y; Li Y; Hu S; Qian J
    Front Cell Infect Microbiol; 2023; 13():1129043. PubMed ID: 36814443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by
    Kulecka M; Zeber-Lubecka N; Bałabas A; Czarnowski P; Bagińska K; Głowienka M; Kluska A; Piątkowska M; Dąbrowska M; Waker E; Mikula M; Ostrowski J
    Front Cell Infect Microbiol; 2023; 13():1190910. PubMed ID: 37577378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection.
    Sokol H; Jegou S; McQuitty C; Straub M; Leducq V; Landman C; Kirchgesner J; Le Gall G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Richard ML; Beaugerie L
    Gut Microbes; 2018 Jan; 9(1):55-60. PubMed ID: 28786749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
    Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Hontecillas R
    Inflamm Bowel Dis; 2024 Jan; 30(1):103-113. PubMed ID: 37436905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
    Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage.
    Cao Y; Wang L; Ke S; Villafuerte Gálvez JA; Pollock NR; Barrett C; Sprague R; Daugherty K; Xu H; Lin Q; Yao J; Chen Y; Kelly CP; Liu YY; Chen X
    Gastroenterology; 2021 Jun; 160(7):2328-2339.e6. PubMed ID: 33684427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridioides difficile infection in inflammatory bowel disease: a clinical review.
    Tang M; Wang C; Xia Y; Tang J; Wang J; Shen L
    Expert Rev Anti Infect Ther; 2024 May; 22(5):297-306. PubMed ID: 38676422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Fecal Bacterial Diversity and Altered Microbiome in Children Colonized With Clostridium difficile.
    Chen LA; Hourigan SK; Grigoryan Z; Gao Z; Clemente JC; Rideout JR; Chirumamilla S; Rabidazeh S; Saeed S; Elson CO; Oliva-Hemker M; Blaser MJ; Sears CL
    J Pediatr Gastroenterol Nutr; 2019 Apr; 68(4):502-508. PubMed ID: 30540709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease.
    Bushman FD; Conrad M; Ren Y; Zhao C; Gu C; Petucci C; Kim MS; Abbas A; Downes KJ; Devas N; Mattei LM; Breton J; Kelsen J; Marakos S; Galgano A; Kachelries K; Erlichman J; Hart JL; Moraskie M; Kim D; Zhang H; Hofstaedter CE; Wu GD; Lewis JD; Zackular JP; Li H; Bittinger K; Baldassano R
    Cell Host Microbe; 2020 Sep; 28(3):422-433.e7. PubMed ID: 32822584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
    Cook L; Wong MQ; Rees WD; Schick A; Lisko DJ; Lunken GR; Wang X; Peters H; Oliveira L; Lau T; Mah R; Bressler B; Levings MK; Steiner TS
    Inflamm Bowel Dis; 2024 May; 30(5):820-828. PubMed ID: 37874904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Lee MR; Kim ES
    Korean J Gastroenterol; 2022 Aug; 80(2):66-71. PubMed ID: 36004633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.
    Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC
    mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
    Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
    Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.
    Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H
    Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.